Headlines
-
FIP adds to COVID-19 guidance
Thursday | Nov 19 2020THE International Pharmaceutical Federation (FIP) has issued an addendum to its COVID-19 guidance following recent developments relating to vaccines and treatment for the pandemic virus.
-
NSW budgets for RTPM
Wednesday | Nov 18 2020FUNDING is set to be made available to deliver a real time prescription monitoring (RTPM) system in NSW.
-
Time to back pharmacy schools
Wednesday | Nov 18 2020COMMUNITY pharmacy owners are being urged to work with their local universities to encourage students to pursue careers in the profession.
-
SSRI script volumes on the rise
Wednesday | Nov 18 2020DATA from the Capital Chemist Group shows an 8.6% rise in prescription volumes for selective serotonin reuptake inhibitors (SSRIs) for the year to date, potentially showing the impact of the bushfire and COVID-19 crises.
-
Pharmacy’s SA COVAX role uncertain
Tuesday | Nov 17 2020SOUTH Australian Health Minister, Stephen Wade, believes it is too early to tell whether or not pharmacists will play a role in administering COVID-19 vaccines (COVAX) in the State.
-
UTS report shows high cost of UTIs
Tuesday | Nov 17 2020ANTIMICROBIAL resistance to urinary tract infections (UTIs) is set to cost Australia $1.6 billion a year by 2030, research from the University of Technology Sydney (UTS) and the OUTBREAK consortium reveals.
-
Corum eyes growth
Tuesday | Nov 17 2020PHARMACY software provider, Corum Group, is aiming to recapture its status as the biggest player in the market with its dispense and retail solutions.
-
Travel boost for APP2021
Monday | Nov 16 2020MOVES to ease travel restrictions in the lead up to Christmas are set to open the door for in-person pharmacy events in 2021.
-
Victoria to broaden naloxone access
Monday | Nov 16 2020LEGISLATION put to the Victorian Legislative Assembly last week is set to widen the authorisations to supply hypodermic needles and supply, possess and administer naloxone.
-
Harvey quits as Choice’s TGACC rep
Monday | Nov 16 2020DISILLUSIONED by the Therapeutic Goods Administration's (TGA) handling of complaints relating to the marketing of healthcare products, public health advocate, Dr Ken Harvey, has resigned from the Therapeutic Goods Advertising Consultative Committee (TGACC).
